Kilitch Drugs (India) Ltd 28 May 2024 12:00 AM
Kilitch Drugs (India) consolidated net profit rises 0.84% in the March 2024 quarter,
Net profit of Kilitch Drugs (India) rose 0.84% to Rs 3.59 crore in the quarter ended March 2024 as against Rs 3.56 crore during the previous quarter ended March 2023. Sales declined 1.45% to Rs 44.82 crore in the quarter ended March 2024 as against Rs 45.48 crore during the previous quarter ended March 2023.For the full year,net profit rose 39.71% to Rs 14.60 crore in the year ended March 2024 as against Rs 10.45 crore during the previous year ended March 2023. Sales rose 10.58% to Rs 154.37 crore in the year ended March 2024 as against Rs 139.60 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales44.8245.48 -1 154.37139.60 11 OPM %15.8013.65 -15.6412.58 - PBDT6.236.03 3 22.7015.56 46 PBT5.305.11 4 19.3512.01 61 NP3.593.56 1 14.6010.45 40 Powered by Capital Market - Live News
Kilitch Drugs (India) Ltd 20 May 2024 12:00 AM
Kilitch Drugs (India) to declare Quarterly Result,
Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 27 May 2024Powered by Capital Market - Live News
Kilitch Drugs (India) Ltd 09 Feb 2024 12:00 AM
Kilitch Drugs (India) consolidated net profit rises 22.78% in the December 2023 quarter,
Net profit of Kilitch Drugs (India) rose 22.78% to Rs 2.91 crore in the quarter ended December 2023 as against Rs 2.37 crore during the previous quarter ended December 2022. Sales rose 6.07% to Rs 31.79 crore in the quarter ended December 2023 as against Rs 29.97 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales31.7929.97 6 OPM %7.1713.28 - PBDT3.643.38 8 PBT2.822.45 15 NP2.912.37 23 Powered by Capital Market - Live News
Kilitch Drugs (India) Ltd 01 Feb 2024 12:00 AM
Kilitch Drugs (India) to conduct board meeting,
Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News
Kilitch Drugs (India) Ltd 10 Nov 2023 12:00 AM
Kilitch Drugs (India) consolidated net profit rises 95.06% in the September 2023 quarter,
Net profit of Kilitch Drugs (India) rose 95.06% to Rs 4.74 crore in the quarter ended September 2023 as against Rs 2.43 crore during the previous quarter ended September 2022. Sales rose 34.20% to Rs 41.20 crore in the quarter ended September 2023 as against Rs 30.70 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales41.2030.70 34 OPM %20.9212.87 - PBDT7.602.44 211 PBT6.781.55 337 NP4.742.43 95 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now